查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球肺氣腫治療市場規模、份額和行業趨勢分析報告：按藥物類型、分銷渠道（藥店和零售藥房、醫院藥房、在線供應商）、區域展望和預測2022-2028
市場調查報告書
商品編碼
1219863

全球肺氣腫治療市場規模、份額和行業趨勢分析報告：按藥物類型、分銷渠道（藥店和零售藥房、醫院藥房、在線供應商）、區域展望和預測2022-2028

Global Emphysema Treatment Market Size, Share & Industry Trends Analysis Report By Medication Type, By Distribution Channel (Drug Stores & Retail Pharmacies, Hospital Pharmacies, and Online Providers), By Regional Outlook and Forecast, 2022 - 2028
出版日期: | 出版商: KBV Research | 英文 167 Pages | 訂單完成後即時交付

價格

在預測期內，全球肺氣腫治療市場規模預計將以 6.1% 的複合年增長率增長，到 2028 年將達到 60.5 億美元。

肺氣腫的症狀包括但不限於焦慮、悲傷、疲勞、睡眠困難和體重減輕。 肺氣腫的症狀經常被誤診，因為它們與許多其他肺部疾病和其他健康問題有關。 肺氣腫引起的呼吸困難會隨著時間的推移而惡化，並導致稱為慢性阻塞性肺病 (COPD) 的疾病。

COVID-19 影響分析

全球醫療保健行業的流程因 COVID-19 大流行而中斷。 該疾病已導致多個不同部門暫時關閉，包括醫療保健行業的許多不同子領域。 另一方面，COVID-19 大流行對市場發展產生了有利影響。 感染冠狀病毒會引起類似於慢性阻塞性肺病 (COPD) 的症狀。 症狀包括呼吸困難以及肺部和其他部位的富氧血液供應不足。 因此，在大流行期間，對用於治療慢性阻塞性肺病的藥物的需求加速了。

市場增長因素

捲菸消費者數量增加

煙草消費是有史以來最大的公共衛生挑戰之一，奪走了許多人的生命。 世界衛生組織 (WHO) 估計，煙草使用每年導致超過 800 萬人死亡。 其中超過 700 萬直接歸因於使用煙草產品，約 120 萬歸因於接觸非吸煙者的二手煙。 吸煙習慣最常引起肺氣腫。 也有人指出，長期接觸其他肺部刺激物如被動吸煙也可能導致 COPD 的發作。 隨著世界各地越來越多的人吸煙，預計未來對肺氣腫治療的需求會增加。

空氣污染加劇

空氣污染的主要來源是家庭、汽車、工業區和森林火災等燃燒裝置。 此外，顆粒物、一氧化碳、二氧化氮、臭氧和二氧化硫等都是關係人體健康的重要污染物。 無論是室內還是室外，空氣污染都是導致多種疾病的主要原因，也是全球死亡和殘疾的主要原因之一。 此外，世界衛生組織 (WHO) 指出，大約有 24 億人使用受污染的明火和以煤油、生物質（木材、動物糞便、農作物廢料）和煤炭為燃料的簡單爐灶。因此，我們估計我們暴露在達到我們家中有害的空氣污染水平。 這種烹飪方法會造成危險程度的空氣污染。

市場製約因素

影像診斷設備成本

可以通過胸部 X 光診斷肺氣腫，並排除其他可能導致呼吸急促的原因。 但是，由於價格非常高，財力有限，許多欠發達國家的醫院無法投資診斷影像設備。 此外，對診斷的需求如此之高，尤其是在低收入國家，以至於無力購買最先進成像設備的醫院轉而轉而重建成像設備。 因此，有望成為擴大傳染性呼吸道疾病診斷試劑市場的主要障礙。

藥物類型展望

按藥物類型劃分，肺氣腫藥物市場分為支氣管擴張劑、類固醇等。 支氣管擴張劑部分將在 2021 年佔肺氣腫治療市場的最大收入份額。 支氣管擴張劑是一種藥物，可以放鬆肺部肌肉，使呼吸更順暢，同時還能擴張氣道（支氣管），使呼吸更順暢。 這一細分市場的擴大可歸因於對用於治療肺氣腫的支氣管擴張劑的需求增加以及對肺氣腫的認識不斷增加。

分銷渠道前景

肺氣腫治療市場根據分銷渠道細分為在線供應商、藥店和零售藥店以及醫院藥店。 2021 年，在線提供商部分在肺氣腫治療市場中佔據了相當大的收入份額。 這可能與對治療肺氣腫的在線藥物供應商的需求不斷增加有關。 這消除了患者去醫院治療的需要，有助於擴大市場。 越來越多的在線藥品平台也推動了市場的發展。 這是推動行業發展的因素之一。

區域展望

按地區劃分，肺氣腫治療市場分為北美、歐洲、亞太地區和 LAMEA。 到 2021 年，亞太地區將佔肺氣腫治療市場的主要收入份額。 這是由於幾個變量造成的，包括用於生產高質量肺氣腫藥物的支出增加。 越來越多地使用不同的三聯製劑治療肺氣腫也推動了市場的發展。 由於吸煙者人數不斷增加，印度的慢性阻塞性肺病 (COPD) 發病率也是最高的。 這些因素結合在一起，使亞太地區成為肺氣腫治療的誘人需求。

內容

第一章市場範圍與研究方法

  • 市場定義
  • 目的
  • 市場規模
  • 細分
    • 全球肺氣腫藥物市場，按藥物類型
    • 按分銷渠道劃分的全球肺氣腫藥物市場
    • 全球肺氣腫藥物市場，按地區
  • 調查方法

第 2 章市場概述

  • 簡介
    • 概覽
      • 市場構成和情景
  • 影響市場的主要因素
    • 市場驅動力
    • 市場製約因素

第 3 章肺氣腫治療市場的發展戰略

第 4 章全球肺氣腫治療市場：按藥物類型分類

  • 全球支氣管擴張劑市場：按地區
  • 世界類固醇市場：按地區
  • 世界其他地區的世界市場

第 5 章全球肺氣腫藥物市場：按分銷渠道

  • 全球藥店和零售藥店市場，按地區
  • 按地區劃分的全球住院藥房市場
  • 按地區劃分的全球在線提供商市場

第 6 章。全球肺氣腫藥物市場：按地區

  • 北美
    • 按國家/地區劃分的北美肺氣腫藥物市場
      • 美國
      • 加拿大
      • 墨西哥
      • 其他北美地區
  • 歐洲
    • 歐洲肺氣腫治療市場：按國家/地區分類
      • 德國
      • 英國
      • 法國
      • 俄羅斯
      • 西班牙
      • 意大利
      • 其他歐洲
  • 亞太地區
    • 亞太地區肺氣腫藥物的國家/地區市場
      • 中國
      • 日本
      • 印度
      • 韓國
      • 新加坡
      • 馬來西亞
      • 其他亞太地區
  • 拉美
    • LAMEA 肺氣腫治療市場：按國家/地區分類
      • 巴西
      • 阿根廷
      • 阿聯酋
      • 沙特阿拉伯
      • 南非
      • 尼日利亞
      • 其他拉美地區

第七章公司簡介

  • AstraZeneca PLC
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • Viatris, Inc.
  • Orion Corporation
  • GlaxoSmithKline PLC
  • Pfizer, Inc.
  • Hikma Pharmaceuticals PLC
  • Boehringer Ingelheim International Gmbh
  • Verona Pharma Plc

The Global Emphysema Treatment Market size is expected to reach $6.05 billion by 2028, rising at a market growth of 6.1% CAGR during the forecast period.

Due to the excessive inflammation of the alveoli, emphysema is also known as chronic obstructive disease. This is because the condition causes both breathing and exhalation to slow down. Damage caused by emphysema to the air sacs may result in a change in the form of the air sacs or, more often, their destruction. This leads to a reduction in the amount of gas that is exchanged in the lungs, which in turn causes trouble breathing. This occurs because the damage to the alveoli results in inadequate room for air to enter the sacs, which causes air to get trapped within the alveoli.

By treating the patient with bronchodilators and steroids, it is possible to alleviate the patient's shortness of breath and cut down on the required hospitalizations. Chronic obstructive pulmonary disease (also known as COPD) is the third most significant cause of mortality globally, accounting for 3.23 million deaths in 2019. This information comes from the World Health Organization. Countries with low and intermediate incomes are responsible for about 90 percent of all COPD-related fatalities in people under the age of 70. (LMIC). COPD is caused by long-term exposure to toxic gases and particles with individual variables such as events that impact the formation of the lungs in infancy and heredity. Chronic obstructive pulmonary disease (COPD) results in ongoing and progressively worsening respiratory symptoms, such as difficulty breathing, coughing, and producing phlegm.

Other symptoms may include but are not limited to anxiety, sadness, weariness, difficulty sleeping, and weight loss. Emphysema is often misdiagnosed since the symptoms it displays are also associated with a variety of other lung illnesses and other health issues. The difficulty breathing brought on by emphysema may worsen over time and lead to a condition known as a chronic obstructive pulmonary disease (COPD).

COVID-19 Impact Analysis

The global healthcare industry has seen a disruption in processes due to the COVID-19 pandemic. The sickness has caused several different sectors, including numerous different sub-domains of the healthcare industry, to close their doors temporarily. On the other hand, the COVID-19 pandemic had a beneficial influence on the development of the market. Patients infected with the coronavirus basically suffer from the same symptoms as those with chronic obstructive pulmonary disease (COPD). These symptoms include difficulty breathing and an inadequate supply of oxygen-rich blood to the lungs and the rest of the body. As a result, the demand for drugs used to cure chronic obstructive pulmonary disease accelerated during the pandemic.

Market Growth Factors

Rising Number Of Tobacco Consumers

Tobacco consumption is one of the most significant challenges to the world's public health that it has ever encountered, and it is responsible for the deaths of many individuals. According to projections made by the World Health Organization, tobacco use results in more than 8 million deaths each year. More than 7 million of these fatalities are directly attributable to the use of tobacco products, while around 1.2 million are attributable to the exposure of non-smokers to second-hand smoke. The habit of smoking cigarettes almost often brings on emphysema. In addition, there is evidence that chronic exposure to other lung irritants, such as passive smoking, may also contribute to the development of COPD. As a result of the growing number of people who smoke tobacco throughout the globe, it is projected that the need for emphysema treatment will also rise in the years to come.

Increasing Levels Of Air Pollution

The most prevalent contributors to air pollution are combustion appliances found in homes, motor vehicles, industrial sites, and forest fires. In addition, particulate matter, carbon monoxide, nitrogen dioxide, ozone, and sulphur dioxide are significant pollutants that concern the public's health. Air pollution, both outside and inside, is a significant contributor to various illnesses and is one of the leading causes of death and disability worldwide. In addition, the World Health Organization (WHO) estimates that approximately 2.4 billion people are subjected to potentially harmful levels of air pollution in their homes as a result of their use of polluting open fires or simple stoves for cooking that are fueled by kerosene, biomass (wood, animal dung, and crop waste), and coal. These types of cooking methods produce dangerous levels of air pollution.

Market Restraining Factors

Expenses Incurred For Imaging Equipment

It is possible to support a diagnosis of advanced emphysema with an X-ray of the chest and rule out other potential reasons for shortness of breath. However, because of the prohibitively high prices and limited financial resources, many hospitals in underdeveloped countries cannot invest in diagnostic imaging equipment. Furthermore, because of the strong demand for diagnostic procedures, particularly in low-income countries, hospitals who do not have the financial resources to purchase brand-new imaging systems that are on the bleeding edge of technology decide instead to employ imaging systems that have been rebuilt. As a result, throughout the time that is anticipated, this aspect will constitute a substantial obstacle to the expansion of the market for infectious respiratory illness diagnostics.

Medication Type Outlook

Based on Medication Type, the Emphysema Treatment Market is segmented into Bronchodilators, steroids, and others. In the emphysema treatment market in 2021, the bronchodilators segment accounted for the largest revenue share. Bronchodilators are a class of drugs that relax the muscles in the lungs, which makes breathing easier, and widens the airways, which also makes breathing easier (bronchi). The expansion of this market segment may be attributed to an increase in the demand for bronchodilators as a therapy for emphysema and increased knowledge about the condition.

Distribution Channel Outlook

Based on the distribution channel, the Emphysema Treatment Market is classified into online providers, drug stores & retail pharmacies, and hospital pharmacies. The online providers segment registered a considerable revenue share in the emphysema treatment market in 2021. This may be linked to the fact that there has been an increase in demand for online providers that provide pharmaceuticals for the treatment of emphysema. This eliminates the need for patients to go to hospitals for treatment, contributing to the market expansion. In addition, a growing number of online platforms for medicine delivery is also driving the market. This is another factor that is driving the industry.

Regional Outlook

Based on region, the Emphysema Treatment Market is segmented into North America, Europe, Asia Pacific, and LAMEA. In 2021, the Asia Pacific region accounted for a significant revenue share in the emphysema treatment market. This is because of several variables, including an increase in spending in producing high-quality medications for emphysema. The increasing use of different triple combination formulations for the treatment of emphysema is also driving the expansion of the market. In addition, due to an increase in the number of people who smoke, India has the highest chronic obstructive pulmonary disease (COPD) rate. These factors combine to make Asia-Pacific an attractive need for emphysema treatment.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AstraZeneca PLC, Teva Pharmaceuticals Industries Ltd., Novartis AG, Viatris, Inc., Orion Corporation, GlaxoSmithKline PLC, Pfizer, Inc., Hikma Pharmaceuticals PLC, Boehringer Ingelheim International GmbH and Verona Pharma Plc.

Strategies Deployed in Emphysema Treatment Market

Jan-2023: AstraZeneca Plc received the US approval for Airsupra. Airsupra was formerly known as PT027. Airsupra is a pressurized metered-dose inhaler (pMDI), fixed-dose combination rescue medication containing albuterol and an anti-inflammatory inhaled corticosteroid (ICS) in the US and is being developed by Avillion and AstraZeneca. Furthermore, Airsupra is used for the treatment or prevention of bronchoconstriction.

Nov-2022: AstraZeneca Plc came into partnership with C4X Discovery Holdings, a Drug Discovery company. Under this partnership, AstraZeneca Plc would be able to develop and deal with an oral treatment for the chronic obstructive pulmonary disease (COPD), respiratory illnesses, and inflammatory illnesses as well. Moreover, both partners would be focusing on creating C4XD's NRF2 Activator program with a primary focus on COPD.

Apr-2022: GlaxoSmithKline Plc Pharmaceuticals Limited unveiled the Trelegy Ellipta. Trelegy Ellipta is the first single-inhaler triple therapy (SITT) in India for Chronic Obstructive Pulmonary Disease (COPD) patients. Moreover, healthcare professionals have a new once-daily, single inhaler triple therapy for the excellent treatment of their COPD patients in India.

Mar-2022: Viatris Inc. and Kindeva Drug Delivery L.P. received the U.S. Food and Drug Administration (FDA) approval for Breyna(Budesonide and Formoterol Fumarate Dihydrate Inhalation Aerosol). Breyna is a drug-device combination product that is meant for certain patients with chronic obstructive pulmonary disease (COPD) or Asthma. This new drug device would be available in 80 mcg/4.5 mcg and 160 mcg/4.5 mcg dosage strengths.

Jul-2021: GlaxoSmithKline plc received the US Food and Drug Administration (FDA) approval for the Nucala (mepolizumab). Nucala (mepolizumab) is a monoclonal antibody that targets interleukin-5 (IL-5), as a treatment for patients with chronic rhinosinusitis with nasal polyps (CRSwNP). This is helpful for adult patients 18 years of age and older with inadequate response to nasal corticosteroids.

Jun-2021: Teva Pharmaceuticals Industries Ltd. unveiled the First Generic Version of PERFOROMIST a formoterol fumarate inhalation solution, 20 mcg/2 ML. The new generic version is used to treat bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including emphysema and chronic bronchitis.

Dec-2020: AstraZeneca PLC received the approval from European Union (EU) for Trixeo Aerosphere. Trixeo Aerosphere is used for maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (COPD).

Jul-2020: Novartis AG received the European Commission (EC) approval for Enerzair Breezhaler as a maintenance treatment of asthma in adult patients. This approval contains an optional digital companion with a sensor and an app that delivers medication reminders, inhalation confirmation, and access to objective data to help therapeutic conclusions.

Jul-2020: AstraZeneca Plc received approval from the US for the Breztri Aerosphere. Breztri Aerosphere is used for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Additionally, Breztri Aerosphere is a triple-combination therapy.

Jul-2020: Teva Pharmaceutical Industries Ltd. unveiled the ProAir Digihaler(albuterol sulfate 117 mcg) Inhalation Powder. ProAir Digihaler is the first and only digital rescue inhaler demonstrated in patients that are four years or older for the prevention or treatment of bronchospasm. Additionally, the device comes with built-in Bluetooth ® Wireless Technology sensors that connect to the mobile app and deliver inhaler event information.

Feb-2019: Orion Corporation came into partnership with Propeller Health, a leading digital therapeutics company. Under this partnership, Orion Corporation would be able to combine the Easyhaler line of inhalers for COPD and Asthma with Propeller's digital medicine platform. Moreover, through this step, Orion Corporation would be able to provide its patients and their providers with a unique capability to enhance the user experience of Easyhaler products and aid patients in sufficiently adhering to the treatments.

Jul-2018: Orion Corporation partnered with Menarini Group, an Italian pharmaceutical company. Under this partnership, Orion Corporation would be able to commercialize and distribute Orion's Easyhaler products in 10 countries in the Asia-Pacific region. Furthermore, the countries involved are Thailand, Singapore, South Korea, China, The Philippines, Indonesia, Taiwan, Malaysia, Hong Kong, and Vietnam.

Scope of the Study

Market Segments covered in the Report:

By Medication Type

  • Bronchodilators
  • Steroids
  • Others

By Distribution Channel

  • Drug Stores & Retail Pharmacies
  • Hospital Pharmacies
  • Online Providers

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • AstraZeneca PLC
  • Teva Pharmaceuticals Industries Ltd.
  • Novartis AG
  • Viatris, Inc.
  • Orion Corporation
  • GlaxoSmithKline PLC
  • Pfizer, Inc.
  • Hikma Pharmaceuticals PLC
  • Boehringer Ingelheim International GmbH
  • Verona Pharma Plc

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Emphysema Treatment Market, by Medication Type
    • 1.4.2 Global Emphysema Treatment Market, by Distribution Channel
    • 1.4.3 Global Emphysema Treatment Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition & Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Strategies Deployed in Emphysema Treatment Market

Chapter 4. Global Emphysema Treatment Market by Medication Type

  • 4.1 Global Bronchodilators Market by Region
  • 4.2 Global Steroids Market by Region
  • 4.3 Global Others Market by Region

Chapter 5. Global Emphysema Treatment Market by Distribution Channel

  • 5.1 Global Drug Stores & Retail Pharmacies Market by Region
  • 5.2 Global Hospital Pharmacies Market by Region
  • 5.3 Global Online Providers Market by Region

Chapter 6. Global Emphysema Treatment Market by Region

  • 6.1 North America Emphysema Treatment Market
    • 6.1.1 North America Emphysema Treatment Market by Medication Type
      • 6.1.1.1 North America Bronchodilators Market by Country
      • 6.1.1.2 North America Steroids Market by Country
      • 6.1.1.3 North America Others Market by Country
    • 6.1.2 North America Emphysema Treatment Market by Distribution Channel
      • 6.1.2.1 North America Drug Stores & Retail Pharmacies Market by Country
      • 6.1.2.2 North America Hospital Pharmacies Market by Country
      • 6.1.2.3 North America Online Providers Market by Country
    • 6.1.3 North America Emphysema Treatment Market by Country
      • 6.1.3.1 US Emphysema Treatment Market
        • 6.1.3.1.1 US Emphysema Treatment Market by Medication Type
        • 6.1.3.1.2 US Emphysema Treatment Market by Distribution Channel
      • 6.1.3.2 Canada Emphysema Treatment Market
        • 6.1.3.2.1 Canada Emphysema Treatment Market by Medication Type
        • 6.1.3.2.2 Canada Emphysema Treatment Market by Distribution Channel
      • 6.1.3.3 Mexico Emphysema Treatment Market
        • 6.1.3.3.1 Mexico Emphysema Treatment Market by Medication Type
        • 6.1.3.3.2 Mexico Emphysema Treatment Market by Distribution Channel
      • 6.1.3.4 Rest of North America Emphysema Treatment Market
        • 6.1.3.4.1 Rest of North America Emphysema Treatment Market by Medication Type
        • 6.1.3.4.2 Rest of North America Emphysema Treatment Market by Distribution Channel
  • 6.2 Europe Emphysema Treatment Market
    • 6.2.1 Europe Emphysema Treatment Market by Medication Type
      • 6.2.1.1 Europe Bronchodilators Market by Country
      • 6.2.1.2 Europe Steroids Market by Country
      • 6.2.1.3 Europe Others Market by Country
    • 6.2.2 Europe Emphysema Treatment Market by Distribution Channel
      • 6.2.2.1 Europe Drug Stores & Retail Pharmacies Market by Country
      • 6.2.2.2 Europe Hospital Pharmacies Market by Country
      • 6.2.2.3 Europe Online Providers Market by Country
    • 6.2.3 Europe Emphysema Treatment Market by Country
      • 6.2.3.1 Germany Emphysema Treatment Market
        • 6.2.3.1.1 Germany Emphysema Treatment Market by Medication Type
        • 6.2.3.1.2 Germany Emphysema Treatment Market by Distribution Channel
      • 6.2.3.2 UK Emphysema Treatment Market
        • 6.2.3.2.1 UK Emphysema Treatment Market by Medication Type
        • 6.2.3.2.2 UK Emphysema Treatment Market by Distribution Channel
      • 6.2.3.3 France Emphysema Treatment Market
        • 6.2.3.3.1 France Emphysema Treatment Market by Medication Type
        • 6.2.3.3.2 France Emphysema Treatment Market by Distribution Channel
      • 6.2.3.4 Russia Emphysema Treatment Market
        • 6.2.3.4.1 Russia Emphysema Treatment Market by Medication Type
        • 6.2.3.4.2 Russia Emphysema Treatment Market by Distribution Channel
      • 6.2.3.5 Spain Emphysema Treatment Market
        • 6.2.3.5.1 Spain Emphysema Treatment Market by Medication Type
        • 6.2.3.5.2 Spain Emphysema Treatment Market by Distribution Channel
      • 6.2.3.6 Italy Emphysema Treatment Market
        • 6.2.3.6.1 Italy Emphysema Treatment Market by Medication Type
        • 6.2.3.6.2 Italy Emphysema Treatment Market by Distribution Channel
      • 6.2.3.7 Rest of Europe Emphysema Treatment Market
        • 6.2.3.7.1 Rest of Europe Emphysema Treatment Market by Medication Type
        • 6.2.3.7.2 Rest of Europe Emphysema Treatment Market by Distribution Channel
  • 6.3 Asia Pacific Emphysema Treatment Market
    • 6.3.1 Asia Pacific Emphysema Treatment Market by Medication Type
      • 6.3.1.1 Asia Pacific Bronchodilators Market by Country
      • 6.3.1.2 Asia Pacific Steroids Market by Country
      • 6.3.1.3 Asia Pacific Others Market by Country
    • 6.3.2 Asia Pacific Emphysema Treatment Market by Distribution Channel
      • 6.3.2.1 Asia Pacific Drug Stores & Retail Pharmacies Market by Country
      • 6.3.2.2 Asia Pacific Hospital Pharmacies Market by Country
      • 6.3.2.3 Asia Pacific Online Providers Market by Country
    • 6.3.3 Asia Pacific Emphysema Treatment Market by Country
      • 6.3.3.1 China Emphysema Treatment Market
        • 6.3.3.1.1 China Emphysema Treatment Market by Medication Type
        • 6.3.3.1.2 China Emphysema Treatment Market by Distribution Channel
      • 6.3.3.2 Japan Emphysema Treatment Market
        • 6.3.3.2.1 Japan Emphysema Treatment Market by Medication Type
        • 6.3.3.2.2 Japan Emphysema Treatment Market by Distribution Channel
      • 6.3.3.3 India Emphysema Treatment Market
        • 6.3.3.3.1 India Emphysema Treatment Market by Medication Type
        • 6.3.3.3.2 India Emphysema Treatment Market by Distribution Channel
      • 6.3.3.4 South Korea Emphysema Treatment Market
        • 6.3.3.4.1 South Korea Emphysema Treatment Market by Medication Type
        • 6.3.3.4.2 South Korea Emphysema Treatment Market by Distribution Channel
      • 6.3.3.5 Singapore Emphysema Treatment Market
        • 6.3.3.5.1 Singapore Emphysema Treatment Market by Medication Type
        • 6.3.3.5.2 Singapore Emphysema Treatment Market by Distribution Channel
      • 6.3.3.6 Malaysia Emphysema Treatment Market
        • 6.3.3.6.1 Malaysia Emphysema Treatment Market by Medication Type
        • 6.3.3.6.2 Malaysia Emphysema Treatment Market by Distribution Channel
      • 6.3.3.7 Rest of Asia Pacific Emphysema Treatment Market
        • 6.3.3.7.1 Rest of Asia Pacific Emphysema Treatment Market by Medication Type
        • 6.3.3.7.2 Rest of Asia Pacific Emphysema Treatment Market by Distribution Channel
  • 6.4 LAMEA Emphysema Treatment Market
    • 6.4.1 LAMEA Emphysema Treatment Market by Medication Type
      • 6.4.1.1 LAMEA Bronchodilators Market by Country
      • 6.4.1.2 LAMEA Steroids Market by Country
      • 6.4.1.3 LAMEA Others Market by Country
    • 6.4.2 LAMEA Emphysema Treatment Market by Distribution Channel
      • 6.4.2.1 LAMEA Drug Stores & Retail Pharmacies Market by Country
      • 6.4.2.2 LAMEA Hospital Pharmacies Market by Country
      • 6.4.2.3 LAMEA Online Providers Market by Country
    • 6.4.3 LAMEA Emphysema Treatment Market by Country
      • 6.4.3.1 Brazil Emphysema Treatment Market
        • 6.4.3.1.1 Brazil Emphysema Treatment Market by Medication Type
        • 6.4.3.1.2 Brazil Emphysema Treatment Market by Distribution Channel
      • 6.4.3.2 Argentina Emphysema Treatment Market
        • 6.4.3.2.1 Argentina Emphysema Treatment Market by Medication Type
        • 6.4.3.2.2 Argentina Emphysema Treatment Market by Distribution Channel
      • 6.4.3.3 UAE Emphysema Treatment Market
        • 6.4.3.3.1 UAE Emphysema Treatment Market by Medication Type
        • 6.4.3.3.2 UAE Emphysema Treatment Market by Distribution Channel
      • 6.4.3.4 Saudi Arabia Emphysema Treatment Market
        • 6.4.3.4.1 Saudi Arabia Emphysema Treatment Market by Medication Type
        • 6.4.3.4.2 Saudi Arabia Emphysema Treatment Market by Distribution Channel
      • 6.4.3.5 South Africa Emphysema Treatment Market
        • 6.4.3.5.1 South Africa Emphysema Treatment Market by Medication Type
        • 6.4.3.5.2 South Africa Emphysema Treatment Market by Distribution Channel
      • 6.4.3.6 Nigeria Emphysema Treatment Market
        • 6.4.3.6.1 Nigeria Emphysema Treatment Market by Medication Type
        • 6.4.3.6.2 Nigeria Emphysema Treatment Market by Distribution Channel
      • 6.4.3.7 Rest of LAMEA Emphysema Treatment Market
        • 6.4.3.7.1 Rest of LAMEA Emphysema Treatment Market by Medication Type
        • 6.4.3.7.2 Rest of LAMEA Emphysema Treatment Market by Distribution Channel

Chapter 7. Company Profiles

  • 7.1 AstraZeneca PLC
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Regional Analysis
    • 7.1.4 Research & Development Expenses
    • 7.1.5 Recent strategies and developments:
      • 7.1.5.1 Partnerships, Collaborations, and Agreements:
      • 7.1.5.2 Approvals and Trials:
  • 7.2 Teva Pharmaceutical Industries Ltd.
    • 7.2.1 Company Overview
    • 7.2.2 Financial Analysis
    • 7.2.3 Regional Analysis
    • 7.2.4 Research & Development Expenses
    • 7.2.5 Recent strategies and developments:
      • 7.2.5.1 Product Launches and Product Expansions:
  • 7.3 Novartis AG
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Segmental and Regional Analysis
    • 7.3.4 Research & Development Expense
    • 7.3.5 Recent strategies and developments:
      • 7.3.5.1 Approvals and Trials:
  • 7.4 Viatris, Inc.
    • 7.4.1 Company Overview
    • 7.4.2 Financial Analysis
    • 7.4.3 Segmental and Regional Analysis
    • 7.4.4 Research & Development Expense
    • 7.4.5 Recent strategies and developments:
      • 7.4.5.1 Approvals and Trials:
  • 7.5 Orion Corporation
    • 7.5.1 Company Overview
    • 7.5.2 Financial Analysis
    • 7.5.3 Regional Analysis
    • 7.5.4 Research & Development Expenses
    • 7.5.5 Recent strategies and developments:
      • 7.5.5.1 Partnerships, Collaborations, and Agreements:
  • 7.6 GlaxoSmithKline PLC
    • 7.6.1 Company Overview
    • 7.6.2 Financial Analysis
    • 7.6.3 Segmental and Regional Analysis
    • 7.6.4 Research & Development Expense
    • 7.6.5 Recent strategies and developments:
      • 7.6.5.1 Product Launches and Product Expansions:
      • 7.6.5.2 Approvals and Trials:
  • 7.7 Pfizer, Inc.
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Regional & Segmental Analysis
    • 7.7.4 Research & Development Expense
  • 7.8 Hikma Pharmaceuticals PLC
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Segmental and Regional Analysis
    • 7.8.4 Research & Development Expenses
  • 7.9 Boehringer Ingelheim International Gmbh
    • 7.9.1 Company Overview
    • 7.9.2 Financial Analysis
    • 7.9.3 Regional & Segmental Analysis
    • 7.9.4 Research & Development Expenses
  • 7.10. Verona Pharma Plc
    • 7.10.1 Company Overview
    • 7.10.2 Financial Analysis
    • 7.10.3 Research & Development Expenses

LIST OF TABLES

  • TABLE 1 Global Emphysema Treatment Market, 2018 - 2021, USD Million
  • TABLE 2 Global Emphysema Treatment Market, 2022 - 2028, USD Million
  • TABLE 3 Global Emphysema Treatment Market by Medication Type, 2018 - 2021, USD Million
  • TABLE 4 Global Emphysema Treatment Market by Medication Type, 2022 - 2028, USD Million
  • TABLE 5 Global Bronchodilators Market by Region, 2018 - 2021, USD Million
  • TABLE 6 Global Bronchodilators Market by Region, 2022 - 2028, USD Million
  • TABLE 7 Global Steroids Market by Region, 2018 - 2021, USD Million
  • TABLE 8 Global Steroids Market by Region, 2022 - 2028, USD Million
  • TABLE 9 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 10 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 11 Global Emphysema Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 12 Global Emphysema Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 13 Global Drug Stores & Retail Pharmacies Market by Region, 2018 - 2021, USD Million
  • TABLE 14 Global Drug Stores & Retail Pharmacies Market by Region, 2022 - 2028, USD Million
  • TABLE 15 Global Hospital Pharmacies Market by Region, 2018 - 2021, USD Million
  • TABLE 16 Global Hospital Pharmacies Market by Region, 2022 - 2028, USD Million
  • TABLE 17 Global Online Providers Market by Region, 2018 - 2021, USD Million
  • TABLE 18 Global Online Providers Market by Region, 2022 - 2028, USD Million
  • TABLE 19 Global Emphysema Treatment Market by Region, 2018 - 2021, USD Million
  • TABLE 20 Global Emphysema Treatment Market by Region, 2022 - 2028, USD Million
  • TABLE 21 North America Emphysema Treatment Market, 2018 - 2021, USD Million
  • TABLE 22 North America Emphysema Treatment Market, 2022 - 2028, USD Million
  • TABLE 23 North America Emphysema Treatment Market by Medication Type, 2018 - 2021, USD Million
  • TABLE 24 North America Emphysema Treatment Market by Medication Type, 2022 - 2028, USD Million
  • TABLE 25 North America Bronchodilators Market by Country, 2018 - 2021, USD Million
  • TABLE 26 North America Bronchodilators Market by Country, 2022 - 2028, USD Million
  • TABLE 27 North America Steroids Market by Country, 2018 - 2021, USD Million
  • TABLE 28 North America Steroids Market by Country, 2022 - 2028, USD Million
  • TABLE 29 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 30 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 31 North America Emphysema Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 32 North America Emphysema Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 33 North America Drug Stores & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 34 North America Drug Stores & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 35 North America Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 36 North America Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 37 North America Online Providers Market by Country, 2018 - 2021, USD Million
  • TABLE 38 North America Online Providers Market by Country, 2022 - 2028, USD Million
  • TABLE 39 North America Emphysema Treatment Market by Country, 2018 - 2021, USD Million
  • TABLE 40 North America Emphysema Treatment Market by Country, 2022 - 2028, USD Million
  • TABLE 41 US Emphysema Treatment Market, 2018 - 2021, USD Million
  • TABLE 42 US Emphysema Treatment Market, 2022 - 2028, USD Million
  • TABLE 43 US Emphysema Treatment Market by Medication Type, 2018 - 2021, USD Million
  • TABLE 44 US Emphysema Treatment Market by Medication Type, 2022 - 2028, USD Million
  • TABLE 45 US Emphysema Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 46 US Emphysema Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 47 Canada Emphysema Treatment Market, 2018 - 2021, USD Million
  • TABLE 48 Canada Emphysema Treatment Market, 2022 - 2028, USD Million
  • TABLE 49 Canada Emphysema Treatment Market by Medication Type, 2018 - 2021, USD Million
  • TABLE 50 Canada Emphysema Treatment Market by Medication Type, 2022 - 2028, USD Million
  • TABLE 51 Canada Emphysema Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 52 Canada Emphysema Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 53 Mexico Emphysema Treatment Market, 2018 - 2021, USD Million
  • TABLE 54 Mexico Emphysema Treatment Market, 2022 - 2028, USD Million
  • TABLE 55 Mexico Emphysema Treatment Market by Medication Type, 2018 - 2021, USD Million
  • TABLE 56 Mexico Emphysema Treatment Market by Medication Type, 2022 - 2028, USD Million
  • TABLE 57 Mexico Emphysema Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 58 Mexico Emphysema Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 59 Rest of North America Emphysema Treatment Market, 2018 - 2021, USD Million
  • TABLE 60 Rest of North America Emphysema Treatment Market, 2022 - 2028, USD Million
  • TABLE 61 Rest of North America Emphysema Treatment Market by Medication Type, 2018 - 2021, USD Million
  • TABLE 62 Rest of North America Emphysema Treatment Market by Medication Type, 2022 - 2028, USD Million
  • TABLE 63 Rest of North America Emphysema Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 64 Rest of North America Emphysema Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 65 Europe Emphysema Treatment Market, 2018 - 2021, USD Million
  • TABLE 66 Europe Emphysema Treatment Market, 2022 - 2028, USD Million
  • TABLE 67 Europe Emphysema Treatment Market by Medication Type, 2018 - 2021, USD Million
  • TABLE 68 Europe Emphysema Treatment Market by Medication Type, 2022 - 2028, USD Million
  • TABLE 69 Europe Bronchodilators Market by Country, 2018 - 2021, USD Million
  • TABLE 70 Europe Bronchodilators Market by Country, 2022 - 2028, USD Million
  • TABLE 71 Europe Steroids Market by Country, 2018 - 2021, USD Million
  • TABLE 72 Europe Steroids Market by Country, 2022 - 2028, USD Million
  • TABLE 73 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 74 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 75 Europe Emphysema Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 76 Europe Emphysema Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 77 Europe Drug Stores & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 78 Europe Drug Stores & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 79 Europe Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 80 Europe Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 81 Europe Online Providers Market by Country, 2018 - 2021, USD Million
  • TABLE 82 Europe Online Providers Market by Country, 2022 - 2028, USD Million
  • TABLE 83 Europe Emphysema Treatment Market by Country, 2018 - 2021, USD Million
  • TABLE 84 Europe Emphysema Treatment Market by Country, 2022 - 2028, USD Million
  • TABLE 85 Germany Emphysema Treatment Market, 2018 - 2021, USD Million
  • TABLE 86 Germany Emphysema Treatment Market, 2022 - 2028, USD Million
  • TABLE 87 Germany Emphysema Treatment Market by Medication Type, 2018 - 2021, USD Million
  • TABLE 88 Germany Emphysema Treatment Market by Medication Type, 2022 - 2028, USD Million
  • TABLE 89 Germany Emphysema Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 90 Germany Emphysema Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 91 UK Emphysema Treatment Market, 2018 - 2021, USD Million
  • TABLE 92 UK Emphysema Treatment Market, 2022 - 2028, USD Million
  • TABLE 93 UK Emphysema Treatment Market by Medication Type, 2018 - 2021, USD Million
  • TABLE 94 UK Emphysema Treatment Market by Medication Type, 2022 - 2028, USD Million
  • TABLE 95 UK Emphysema Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 96 UK Emphysema Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 97 France Emphysema Treatment Market, 2018 - 2021, USD Million
  • TABLE 98 France Emphysema Treatment Market, 2022 - 2028, USD Million
  • TABLE 99 France Emphysema Treatment Market by Medication Type, 2018 - 2021, USD Million
  • TABLE 100 France Emphysema Treatment Market by Medication Type, 2022 - 2028, USD Million
  • TABLE 101 France Emphysema Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 102 France Emphysema Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 103 Russia Emphysema Treatment Market, 2018 - 2021, USD Million
  • TABLE 104 Russia Emphysema Treatment Market, 2022 - 2028, USD Million
  • TABLE 105 Russia Emphysema Treatment Market by Medication Type, 2018 - 2021, USD Million
  • TABLE 106 Russia Emphysema Treatment Market by Medication Type, 2022 - 2028, USD Million
  • TABLE 107 Russia Emphysema Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 108 Russia Emphysema Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 109 Spain Emphysema Treatment Market, 2018 - 2021, USD Million
  • TABLE 110 Spain Emphysema Treatment Market, 2022 - 2028, USD Million
  • TABLE 111 Spain Emphysema Treatment Market by Medication Type, 2018 - 2021, USD Million
  • TABLE 112 Spain Emphysema Treatment Market by Medication Type, 2022 - 2028, USD Million
  • TABLE 113 Spain Emphysema Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 114 Spain Emphysema Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 115 Italy Emphysema Treatment Market, 2018 - 2021, USD Million
  • TABLE 116 Italy Emphysema Treatment Market, 2022 - 2028, USD Million
  • TABLE 117 Italy Emphysema Treatment Market by Medication Type, 2018 - 2021, USD Million
  • TABLE 118 Italy Emphysema Treatment Market by Medication Type, 2022 - 2028, USD Million
  • TABLE 119 Italy Emphysema Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 120 Italy Emphysema Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 121 Rest of Europe Emphysema Treatment Market, 2018 - 2021, USD Million
  • TABLE 122 Rest of Europe Emphysema Treatment Market, 2022 - 2028, USD Million
  • TABLE 123 Rest of Europe Emphysema Treatment Market by Medication Type, 2018 - 2021, USD Million
  • TABLE 124 Rest of Europe Emphysema Treatment Market by Medication Type, 2022 - 2028, USD Million
  • TABLE 125 Rest of Europe Emphysema Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 126 Rest of Europe Emphysema Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 127 Asia Pacific Emphysema Treatment Market, 2018 - 2021, USD Million
  • TABLE 128 Asia Pacific Emphysema Treatment Market, 2022 - 2028, USD Million
  • TABLE 129 Asia Pacific Emphysema Treatment Market by Medication Type, 2018 - 2021, USD Million
  • TABLE 130 Asia Pacific Emphysema Treatment Market by Medication Type, 2022 - 2028, USD Million
  • TABLE 131 Asia Pacific Bronchodilators Market by Country, 2018 - 2021, USD Million
  • TABLE 132 Asia Pacific Bronchodilators Market by Country, 2022 - 2028, USD Million
  • TABLE 133 Asia Pacific Steroids Market by Country, 2018 - 2021, USD Million
  • TABLE 134 Asia Pacific Steroids Market by Country, 2022 - 2028, USD Million
  • TABLE 135 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 136 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 137 Asia Pacific Emphysema Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 138 Asia Pacific Emphysema Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 139 Asia Pacific Drug Stores & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 140 Asia Pacific Drug Stores & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 141 Asia Pacific Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 142 Asia Pacific Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 143 Asia Pacific Online Providers Market by Country, 2018 - 2021, USD Million
  • TABLE 144 Asia Pacific Online Providers Market by Country, 2022 - 2028, USD Million
  • TABLE 145 Asia Pacific Emphysema Treatment Market by Country, 2018 - 2021, USD Million
  • TABLE 146 Asia Pacific Emphysema Treatment Market by Country, 2022 - 2028, USD Million
  • TABLE 147 China Emphysema Treatment Market, 2018 - 2021, USD Million
  • TABLE 148 China Emphysema Treatment Market, 2022 - 2028, USD Million
  • TABLE 149 China Emphysema Treatment Market by Medication Type, 2018 - 2021, USD Million
  • TABLE 150 China Emphysema Treatment Market by Medication Type, 2022 - 2028, USD Million
  • TABLE 151 China Emphysema Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 152 China Emphysema Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 153 Japan Emphysema Treatment Market, 2018 - 2021, USD Million
  • TABLE 154 Japan Emphysema Treatment Market, 2022 - 2028, USD Million
  • TABLE 155 Japan Emphysema Treatment Market by Medication Type, 2018 - 2021, USD Million
  • TABLE 156 Japan Emphysema Treatment Market by Medication Type, 2022 - 2028, USD Million
  • TABLE 157 Japan Emphysema Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 158 Japan Emphysema Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 159 India Emphysema Treatment Market, 2018 - 2021, USD Million
  • TABLE 160 India Emphysema Treatment Market, 2022 - 2028, USD Million
  • TABLE 161 India Emphysema Treatment Market by Medication Type, 2018 - 2021, USD Million
  • TABLE 162 India Emphysema Treatment Market by Medication Type, 2022 - 2028, USD Million
  • TABLE 163 India Emphysema Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 164 India Emphysema Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 165 South Korea Emphysema Treatment Market, 2018 - 2021, USD Million
  • TABLE 166 South Korea Emphysema Treatment Market, 2022 - 2028, USD Million
  • TABLE 167 South Korea Emphysema Treatment Market by Medication Type, 2018 - 2021, USD Million
  • TABLE 168 South Korea Emphysema Treatment Market by Medication Type, 2022 - 2028, USD Million
  • TABLE 169 South Korea Emphysema Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 170 South Korea Emphysema Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 171 Singapore Emphysema Treatment Market, 2018 - 2021, USD Million
  • TABLE 172 Singapore Emphysema Treatment Market, 2022 - 2028, USD Million
  • TABLE 173 Singapore Emphysema Treatment Market by Medication Type, 2018 - 2021, USD Million
  • TABLE 174 Singapore Emphysema Treatment Market by Medication Type, 2022 - 2028, USD Million
  • TABLE 175 Singapore Emphysema Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 176 Singapore Emphysema Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 177 Malaysia Emphysema Treatment Market, 2018 - 2021, USD Million
  • TABLE 178 Malaysia Emphysema Treatment Market, 2022 - 2028, USD Million
  • TABLE 179 Malaysia Emphysema Treatment Market by Medication Type, 2018 - 2021, USD Million
  • TABLE 180 Malaysia Emphysema Treatment Market by Medication Type, 2022 - 2028, USD Million
  • TABLE 181 Malaysia Emphysema Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 182 Malaysia Emphysema Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 183 Rest of Asia Pacific Emphysema Treatment Market, 2018 - 2021, USD Million
  • TABLE 184 Rest of Asia Pacific Emphysema Treatment Market, 2022 - 2028, USD Million
  • TABLE 185 Rest of Asia Pacific Emphysema Treatment Market by Medication Type, 2018 - 2021, USD Million
  • TABLE 186 Rest of Asia Pacific Emphysema Treatment Market by Medication Type, 2022 - 2028, USD Million
  • TABLE 187 Rest of Asia Pacific Emphysema Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 188 Rest of Asia Pacific Emphysema Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 189 LAMEA Emphysema Treatment Market, 2018 - 2021, USD Million
  • TABLE 190 LAMEA Emphysema Treatment Market, 2022 - 2028, USD Million
  • TABLE 191 LAMEA Emphysema Treatment Market by Medication Type, 2018 - 2021, USD Million
  • TABLE 192 LAMEA Emphysema Treatment Market by Medication Type, 2022 - 2028, USD Million
  • TABLE 193 LAMEA Bronchodilators Market by Country, 2018 - 2021, USD Million
  • TABLE 194 LAMEA Bronchodilators Market by Country, 2022 - 2028, USD Million
  • TABLE 195 LAMEA Steroids Market by Country, 2018 - 2021, USD Million
  • TABLE 196 LAMEA Steroids Market by Country, 2022 - 2028, USD Million
  • TABLE 197 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 198 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 199 LAMEA Emphysema Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 200 LAMEA Emphysema Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 201 LAMEA Drug Stores & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 202 LAMEA Drug Stores & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 203 LAMEA Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 204 LAMEA Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 205 LAMEA Online Providers Market by Country, 2018 - 2021, USD Million
  • TABLE 206 LAMEA Online Providers Market by Country, 2022 - 2028, USD Million
  • TABLE 207 LAMEA Emphysema Treatment Market by Country, 2018 - 2021, USD Million
  • TABLE 208 LAMEA Emphysema Treatment Market by Country, 2022 - 2028, USD Million
  • TABLE 209 Brazil Emphysema Treatment Market, 2018 - 2021, USD Million
  • TABLE 210 Brazil Emphysema Treatment Market, 2022 - 2028, USD Million
  • TABLE 211 Brazil Emphysema Treatment Market by Medication Type, 2018 - 2021, USD Million
  • TABLE 212 Brazil Emphysema Treatment Market by Medication Type, 2022 - 2028, USD Million
  • TABLE 213 Brazil Emphysema Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 214 Brazil Emphysema Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 215 Argentina Emphysema Treatment Market, 2018 - 2021, USD Million
  • TABLE 216 Argentina Emphysema Treatment Market, 2022 - 2028, USD Million
  • TABLE 217 Argentina Emphysema Treatment Market by Medication Type, 2018 - 2021, USD Million
  • TABLE 218 Argentina Emphysema Treatment Market by Medication Type, 2022 - 2028, USD Million
  • TABLE 219 Argentina Emphysema Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 220 Argentina Emphysema Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 221 UAE Emphysema Treatment Market, 2018 - 2021, USD Million
  • TABLE 222 UAE Emphysema Treatment Market, 2022 - 2028, USD Million
  • TABLE 223 UAE Emphysema Treatment Market by Medication Type, 2018 - 2021, USD Million
  • TABLE 224 UAE Emphysema Treatment Market by Medication Type, 2022 - 2028, USD Million
  • TABLE 225 UAE Emphysema Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 226 UAE Emphysema Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 227 Saudi Arabia Emphysema Treatment Market, 2018 - 2021, USD Million
  • TABLE 228 Saudi Arabia Emphysema Treatment Market, 2022 - 2028, USD Million
  • TABLE 229 Saudi Arabia Emphysema Treatment Market by Medication Type, 2018 - 2021, USD Million
  • TABLE 230 Saudi Arabia Emphysema Treatment Market by Medication Type, 2022 - 2028, USD Million
  • TABLE 231 Saudi Arabia Emphysema Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 232 Saudi Arabia Emphysema Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 233 South Africa Emphysema Treatment Market, 2018 - 2021, USD Million
  • TABLE 234 South Africa Emphysema Treatment Market, 2022 - 2028, USD Million
  • TABLE 235 South Africa Emphysema Treatment Market by Medication Type, 2018 - 2021, USD Million
  • TABLE 236 South Africa Emphysema Treatment Market by Medication Type, 2022 - 2028, USD Million
  • TABLE 237 South Africa Emphysema Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 238 South Africa Emphysema Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 239 Nigeria Emphysema Treatment Market, 2018 - 2021, USD Million
  • TABLE 240 Nigeria Emphysema Treatment Market, 2022 - 2028, USD Million
  • TABLE 241 Nigeria Emphysema Treatment Market by Medication Type, 2018 - 2021, USD Million
  • TABLE 242 Nigeria Emphysema Treatment Market by Medication Type, 2022 - 2028, USD Million
  • TABLE 243 Nigeria Emphysema Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 244 Nigeria Emphysema Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 245 Rest of LAMEA Emphysema Treatment Market, 2018 - 2021, USD Million
  • TABLE 246 Rest of LAMEA Emphysema Treatment Market, 2022 - 2028, USD Million
  • TABLE 247 Rest of LAMEA Emphysema Treatment Market by Medication Type, 2018 - 2021, USD Million
  • TABLE 248 Rest of LAMEA Emphysema Treatment Market by Medication Type, 2022 - 2028, USD Million
  • TABLE 249 Rest of LAMEA Emphysema Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 250 Rest of LAMEA Emphysema Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 251 KEY INFORMATION - AstraZeneca PLC
  • TABLE 252 Key Information - Teva Pharmaceuticals Industries Ltd.
  • TABLE 253 Key Information - Novartis AG
  • TABLE 254 key information - Viatris, Inc.
  • TABLE 255 Key Information - Orion Corporation
  • TABLE 256 Key Information - GlaxoSmithKline PLC
  • TABLE 257 Key Information - Pfizer, Inc.
  • TABLE 258 Key Information - Hikma Pharmaceuticals PLC
  • TABLE 259 Key Information - Boehringer Ingelheim International GmbH
  • TABLE 260 Key Information - Verona Pharma Plc

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Global Emphysema Treatment Market share, by Medication Type, 2021
  • FIG 3 Global Emphysema Treatment Market share, by Medication Type, 2028
  • FIG 4 Global Emphysema Treatment Market by Medication Type, 2018 - 2028, USD Million
  • FIG 5 Global Emphysema Treatment Market share, by Distribution Channel, 2021
  • FIG 6 Global Emphysema Treatment Market share, by Distribution Channel, 2028
  • FIG 7 Global Emphysema Treatment Market by Distribution Channel, 2018 - 2028, USD Million
  • FIG 8 Global Emphysema Treatment Market share, by Region, 2021
  • FIG 9 Global Emphysema Treatment Market share, by Region, 2028
  • FIG 10 Global Emphysema Treatment Market by Region, 2018 - 2028, USD Million
  • FIG 11 Recent strategies and developments: AstraZeneca Plc